<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; BID</title>
	<atom:link href="http://www.stockbloghub.com/tag/bid/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Mon, 21 May 2012 16:42:30 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(VRTX) Vertex Pharmaceuticals Reports Positive Data</title>
		<link>http://www.stockbloghub.com/2011/09/12/vrtx-vertex-pharmaceuticals-reports-positive-data/82979</link>
		<comments>http://www.stockbloghub.com/2011/09/12/vrtx-vertex-pharmaceuticals-reports-positive-data/82979#comments</comments>
		<pubDate>Mon, 12 Sep 2011 17:19:46 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Manufacturers - Other]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[BID]]></category>
		<category><![CDATA[Champion Industries Inc]]></category>
		<category><![CDATA[CHMP]]></category>
		<category><![CDATA[EU]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MAA]]></category>
		<category><![CDATA[Mid-America Apartment Communities Inc]]></category>
		<category><![CDATA[RA]]></category>
		<category><![CDATA[Railamerica Inc]]></category>
		<category><![CDATA[Sotheby's]]></category>
		<category><![CDATA[Vertex Pharmaceuticals Incorporated]]></category>
		<category><![CDATA[VRTX]]></category>
		<category><![CDATA[WisdomTree Dreyfus Euro]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82979</guid>
		<description><![CDATA[Vertex Pharmaceuticals Inc. (VRTX) reported positive data from a mid-stage trial on VX-509, which is being studied for the treatment of moderate to severe rheumatoid arthritis (RA). The 12-week study, which evaluated four doses of the candidate, met both the primary endpoints. Data from the two highest dose (100 mg and 150 mg) treatment arms demonstrated significant improvement in the proportion of people who achieved at least a 20% improvement in the signs and symptoms of RA (ACR20), and a statistically significant improvement from baseline in Disease Activity Score 28 (DAS28), compared to placebo. The study also met the secondary endpoints (ACR50 and ACR70) of achieving statistically significant responses compared to placebo. On the basis of the data from the phase IIa study, Vertex Pharma plans to initiate a six-month ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/12/vrtx-vertex-pharmaceuticals-reports-positive-data/82979/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMZN) Company News for March 01, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/03/03/amzn-company-news-for-march-01-2011-corporate-summary/67806</link>
		<comments>http://www.stockbloghub.com/2011/03/03/amzn-company-news-for-march-01-2011-corporate-summary/67806#comments</comments>
		<pubDate>Thu, 03 Mar 2011 21:39:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Catalog & Mail Order Houses]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[Amazon.com Inc]]></category>
		<category><![CDATA[Amerigon Inc]]></category>
		<category><![CDATA[AMZN]]></category>
		<category><![CDATA[ARGN]]></category>
		<category><![CDATA[BID]]></category>
		<category><![CDATA[KCP]]></category>
		<category><![CDATA[Kenneth Cole Productions Inc]]></category>
		<category><![CDATA[MEMC Electronic Materials Inc.]]></category>
		<category><![CDATA[Nationwide Health Properties Inc]]></category>
		<category><![CDATA[NHP]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[PDL BioPharma Inc]]></category>
		<category><![CDATA[PDLI]]></category>
		<category><![CDATA[Sotheby's]]></category>
		<category><![CDATA[TIE]]></category>
		<category><![CDATA[Titanium Metals Corporation]]></category>
		<category><![CDATA[UBS]]></category>
		<category><![CDATA[UBS AG]]></category>
		<category><![CDATA[Ventas Inc.]]></category>
		<category><![CDATA[VTR]]></category>
		<category><![CDATA[WFR]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=67806</guid>
		<description><![CDATA[• Board of Directors of both Ventas, Inc. (NYSE:VTR) and Nationwide Health Properties, Inc. (NYSE:NHP) have approved a definitive merger agreement between the two companies • Titanium Metals (NYSE:TIE) reported Q4 EPS of $0.13, in line with the Zacks Consensus Estimate of $0.13 per share. Revenues for the quarter rose 18% year-over-year to $217.3 million, lower than the Zacks Consensus Estimate of $219.0 million • Sotheby’s (NYSE:BID) reported Q4 EPS of $1.38, in line with the Zacks Consensus Estimate of $1.38 per share. Revenues for the quarter rose 46% year-over-year to $318.5 million, above the Zacks Consensus Estimate of $298.0 million • UBS (NYSE:UBS) downgraded Amazon.com, Inc. (NASDAQ:AMZN) to a ‘neutral’ from a ‘buy’ rating • On Monday, manufacturer of car seats Amerigon Inc (NASDAQ:ARGN) said it would buy 76.6% of Germany’s WET Automotive Systems ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/03/amzn-company-news-for-march-01-2011-corporate-summary/67806/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BID) Sotheby&#8217;s &#8211; Revenue Was Up 31%</title>
		<link>http://www.stockbloghub.com/2010/03/16/bid-sothebys-revenue-was-up-31/30735</link>
		<comments>http://www.stockbloghub.com/2010/03/16/bid-sothebys-revenue-was-up-31/30735#comments</comments>
		<pubDate>Tue, 16 Mar 2010 22:30:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Services]]></category>
		<category><![CDATA[Specialty Retail Other]]></category>
		<category><![CDATA[BID]]></category>
		<category><![CDATA[Sotheby's]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=30735</guid>
		<description><![CDATA[Sotheby&#8217;s (BID) just hit a new 52-week high on the company&#8217;s better than expected Q from early March that were driven by a rebound in the global economy. Company Description Sotheby&#8217;s, together with its subsidiaries, operates as an auctioneer of fine and decorative art, jewelry and collectibles in the United States, China, the U.K. and France. The company was founded in 1744 and has a market cap of $1.95 billion. Sotheby&#8217;s business took a hit in the weak economy of 2008 and early 2009 as wealthy individuals scaled back on high-Dollar expenses. But with a big equity rebound in hand and optimism abound, the company&#8217;s results have once again perked up, on display with better than expected Q4 results from March 1. Fourth-Quarter Results Revenue was up 31% from last ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/16/bid-sothebys-revenue-was-up-31/30735/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(KO) Let China’s Middle Class Lead You Into Luxury</title>
		<link>http://www.stockbloghub.com/2009/10/28/ko-let-china%e2%80%99s-middle-class-lead-you-into-luxury/19086</link>
		<comments>http://www.stockbloghub.com/2009/10/28/ko-let-china%e2%80%99s-middle-class-lead-you-into-luxury/19086#comments</comments>
		<pubDate>Wed, 28 Oct 2009 21:26:04 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Beverages - Soft Drinks]]></category>
		<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[BID]]></category>
		<category><![CDATA[Claymore-Robb Report Global Luxury]]></category>
		<category><![CDATA[Coach Inc.]]></category>
		<category><![CDATA[COH]]></category>
		<category><![CDATA[KO]]></category>
		<category><![CDATA[LUX]]></category>
		<category><![CDATA[Luxottica Group SpA]]></category>
		<category><![CDATA[ROB]]></category>
		<category><![CDATA[Sotheby's]]></category>
		<category><![CDATA[The Coca-Cola Company]]></category>
		<category><![CDATA[TIF]]></category>
		<category><![CDATA[Tiffany & Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=19086</guid>
		<description><![CDATA[Tony Daltorio, Investment U Research According to the World Bank, the global middle class could grow to 1.15 billion in 2030 – a huge jump from the 430 million middle class folks in 2000. Driving the extraordinary growth is… you guessed it, the emerging “BRIC” nations. In 2000, developing countries like China, Brazil and India accounted for 56% of that number. But by 2030, analysts expect it to climb as high as 93%… with China alone accounting for 52% of the expected increase. This represents a tremendous amount of wealth. A Coca-Cola (NYSE: KO) executive compared it to adding a city the size of New York to the world… every three months. Needless to say, that opens up amazing opportunities. But in order to succeed, companies who want to profit ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/28/ko-let-china%e2%80%99s-middle-class-lead-you-into-luxury/19086/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BID) Trailing Stops &amp; Position Sizing: Two Tips to Avoid Letting a Bad Stock Sucker-Punch You</title>
		<link>http://www.stockbloghub.com/2009/10/08/bid-trailing-stops-position-sizing-two-tips-to-avoid-letting-a-bad-stock-sucker-punch-you/17148</link>
		<comments>http://www.stockbloghub.com/2009/10/08/bid-trailing-stops-position-sizing-two-tips-to-avoid-letting-a-bad-stock-sucker-punch-you/17148#comments</comments>
		<pubDate>Thu, 08 Oct 2009 19:40:54 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Services]]></category>
		<category><![CDATA[Specialty Retail Other]]></category>
		<category><![CDATA[BID]]></category>
		<category><![CDATA[HGG]]></category>
		<category><![CDATA[hhgregg]]></category>
		<category><![CDATA[Sotheby's]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=17148</guid>
		<description><![CDATA[by Louis Basenese, Small Cap and Special Situations Expert Thursday, October 8, 2009: Issue #1111 I confess… I got it wrong with gold. Unlike some stockpickers and newsletter analysts, who proudly trumpet all their winners, while shuffling the losers under the rug, I have no problem admitting when my calls go against me. And to the delight of all the naysayers, this happened just a couple of days ago when gold prices shot to a record high. That triggered my sell-stop and, rather than let my pride come before a fall and hang on, it’s time to move on. Don’t get me wrong, though… I’m still convinced that the yellow metal could suffer a correction for three main reasons… So far, inflation hasn’t reared its ugly head. If it stays ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/08/bid-trailing-stops-position-sizing-two-tips-to-avoid-letting-a-bad-stock-sucker-punch-you/17148/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

